Lou Gehrig'S Disease Clinical Trials 2023
Browse 67 Lou Gehrigs Disease Medical Studies Across 113 Cities
11 Phase 3 Trial · 403 Lou Gehrigs Disease Clinics
Reviewed by Michael Gill, B. Sc.
10 Lou Gehrigs Disease Clinical Trials Near Me
Top Hospitals for Lou Gehrigs Disease Clinical Trials
Massachusetts General Hospital
Boston
10Active Trials
62All Time Trials for Lou Gehrigs Disease
2001First Lou Gehrigs Disease Trial
Sunnybrook Health Sciences Centre
Toronto
5Active Trials
13All Time Trials for Lou Gehrigs Disease
2014First Lou Gehrigs Disease Trial
Mayo Clinic
Jacksonville
5Active Trials
15All Time Trials for Lou Gehrigs Disease
2003First Lou Gehrigs Disease Trial
Emory University
Atlanta
5Active Trials
19All Time Trials for Lou Gehrigs Disease
2003First Lou Gehrigs Disease Trial
Top Cities for Lou Gehrigs Disease Clinical Trials
Lou Gehrig's Disease Clinical Trials by Phase of TrialN/A Lou Gehrig's Disease Clinical Trials
Lou Gehrig's Disease Clinical Trials by Age Group19Active Lou Gehrig's Disease Clinical Trials
19Number of Unique Treatments
23Number of Active Locations
18+ Lou Gehrig's Disease Clinical Trials
Most Recent Lou Gehrigs Disease Clinical Trials60Active Lou Gehrig's Disease Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Treatment Name
Active Lou Gehrigs Disease Clinical Trials
All Time Trials for Lou Gehrigs Disease
First Recorded Lou Gehrigs Disease Trial
DNL343
2
3
2020
Treatment
2
2
2003
Accelerated cTBS Neuromodulation
1
1
2023
PTC857
1
1
2022
AP-101
1
2
2019
Treatment
Year
Sponsor
Pridopidine
2020
Merit E. Cudkowicz, MD
AMX0035
2020
Amylyx Pharmaceuticals Inc.
Theracurmin HP
2020
Richard Bedlack, M.D., Ph.D.
CNM-Au8
2020
Merit E. Cudkowicz, MD
Zilucoplan
2020
Merit E. Cudkowicz, MD
Verdiperstat
2020
Merit E. Cudkowicz, MD
About The Author
Michael Gill - B. Sc.
First Published: October 27th, 2021
Last Reviewed: August 14th, 2023
References1 Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9. doi: 10.1080/146608200300079536. No abstract available. https://pubmed.ncbi.nlm.nih.gov/114648472 Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996 Spring;11(2):93-8. https://pubmed.ncbi.nlm.nih.gov/87210663 Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9. Review. https://pubmed.ncbi.nlm.nih.gov/114648474 Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996 Spring;11(2):93-8. doi: 10.1007/BF00417897. https://pubmed.ncbi.nlm.nih.gov/87210665 Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005 Aug;86(8):1516-20. doi: 10.1016/j.apmr.2004.11.049. https://pubmed.ncbi.nlm.nih.gov/160848016 Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999 Oct 31;169(1-2):13-21. https://pubmed.ncbi.nlm.nih.gov/105400027 Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil. 2005 Aug;86(8):1516-20. https://pubmed.ncbi.nlm.nih.gov/160848018 Latham BD, Oskin DS, Crouch RD, Vergne MJ, Jackson KD. Cytochromes P450 2C8 and 3A Catalyze the Metabolic Activation of the Tyrosine Kinase Inhibitor Masitinib. Chem Res Toxicol. 2022 Sep 19;35(9):1467-1481. doi: 10.1021/acs.chemrestox.2c00057. Epub 2022 Sep 1. https://pubmed.ncbi.nlm.nih.gov/360488779 Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011 Jan 20;117(3):1061-70. doi: 10.1182/blood-2010-07-293795. Epub 2010 Oct 15. https://pubmed.ncbi.nlm.nih.gov/2095268710 Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999 Oct 31;169(1-2):13-21. doi: 10.1016/s0022-510x(99)00210-5. https://pubmed.ncbi.nlm.nih.gov/10540002